Skip to main content
Premium Trial:

Request an Annual Quote

Codexis: Stewart Parker

Codexis announced the appointment of Stewart Parker to its board of directors. Parker previously served as CEO of the Infectious Disease Research Institute. Prior to that, she was CEO of Targeted Genetics. Parker has also served on the boards of IMPEL Pharmaceuticals, StrideBio, Achieve Life Sciences, and the BIO trade organization. She holds an MBA in finance and international business from the University of Washington.

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.